Home›Sacubitril And Valsartan›Sacubitril And Valsartan + Valsartan

Does Sacubitril And Valsartan Interact with Valsartan?

CDI records a contraindicated classification for Sacubitril And Valsartan and Valsartan. The stored summary is: (7.4) 7.1 Dual Blockade of the Renin-Angiotensin-Aldosterone System Concomitant use of sacubitril and valsartan with an ACE inhibitor is contraindicated because of the increased risk of angioedema [see Contraindications (4)] . Avoid use of sacubitril and valsartan with an ARB, because sacubitril and valsartan contains the angiotensin II receptor blocker valsartan. The concomitant use of sacubitril and valsartan with aliskiren is contraindicated in patients with diabetes [see Contraindications (4)] . Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity
Contraindicated
Sacubitril And Valsartan Class
Angiotensin 2 Receptor Blocker
Valsartan Class
Angiotensin 2 Receptor Blocker
Management
Do not take together
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Sacubitril And Valsartan and your doctor is considering prescribing Valsartan (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask about alternative medications that do not interact with your current regimen
  • Ask how frequently you should be monitored while these are co-prescribed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Sacubitril And Valsartan(Entresto)+💊 Valsartan(Exforge HCT)

Severity & Interaction Details

⛔
contraindicated
Avoid this combination
CDI classifies this record as contraindicated. Confirm the applicable product labeling with your prescriber or pharmacist.
Severity scale
MinorContra
On record
Yes
Drug A class
Angiotensin 2 Receptor Blocker
Drug B class
Angiotensin 2 Receptor Blocker
Source
FDA drug label - sacubitril and valsartan

What this means in plain English

(7.4) 7.1 Dual Blockade of the Renin-Angiotensin-Aldosterone System Concomitant use of sacubitril and valsartan with an ACE inhibitor is contraindicated because of the increased risk of angioedema [see Contraindications (4)] . Avoid use of sacubitril and valsartan with an ARB, because sacubitril and valsartan contains the angiotensin II receptor blocker valsartan. The concomitant use of sacubitril and valsartan with aliskiren is contraindicated in patients with diabetes [see Contraindications (4)] .

About Sacubitril And Valsartan and Valsartan

Sacubitril And Valsartan and Valsartan both belong to the Angiotensin 2 Receptor Blocker class. You may recognize them by the brand names Entresto and Exforge HCT. Both Sacubitril And Valsartan and Valsartan carry an FDA boxed warning — the agency's most serious safety designation.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: FDA drug label - sacubitril and valsartan

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Sacubitril And Valsartan and Valsartan against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations